Selective CXCR4 antagonism by Tat:: Implications for in vivo expansion of coreceptor use by HIV-1

被引:308
作者
Xiao, H
Neuveut, C
Tiffany, HL
Benkirane, M
Rich, EA
Murphy, PM
Jeang, KT
机构
[1] NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA
[2] NIAID, Host Def Lab, Bethesda, MD 20892 USA
关键词
chemokine antagonist; viral coreceptor;
D O I
10.1073/pnas.97.21.11466
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Chemokines and chemokine receptors play important roles in HIV-1 infection and tropism, CCR5 is the major macrophage-tropic: coreceptor for HIV-1 whereas CXC chemokine receptor 4 (CXCR4) serves the counterpart function for T cell-tropic viruses. An outstanding biological mystery is why only R5-HIV-1 is initially detected in new seroconvertors who are exposed to R5 and X4 viruses. Indeed, X4 virus emerges in a minority of patients and only in the late stage of disease, suggesting that early negative selection against HIV-1-CXCR4 interaction may exist. Here, we report that the HIV-1 Tat protein, which is secreted from virus-infected cells, is a CXCR4-specific antagonist. Soluble Tat selectively inhibited the entry and replication of X4, but not R5, virus in peripheral blood mononuclear cells (PBMCs). We propose that one functional consequence of secreted Tat is to select against X4 viruses, thereby influencing the early in vivo course of HIV-1 disease.
引用
收藏
页码:11466 / 11471
页数:6
相关论文
共 47 条
[1]   ANGIOGENIC PROPERTIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT PROTEIN [J].
ALBINI, A ;
BARILLARI, G ;
BENELLI, R ;
GALLO, RC ;
ENSOLI, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (11) :4838-4842
[2]   CC CKRS: A RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1 [J].
Alkhatib, G ;
Combadiere, C ;
Broder, CC ;
Feng, Y ;
Kennedy, PE ;
Murphy, PM ;
Berger, EA .
SCIENCE, 1996, 272 (5270) :1955-1958
[3]   The neglected role of type I interferon in the T-cell response: Implications for its clinical use [J].
Belardelli, F ;
Gresser, I .
IMMUNOLOGY TODAY, 1996, 17 (08) :369-372
[4]   Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease [J].
Berger, EA ;
Murphy, PM ;
Farber, JM .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :657-700
[5]   A new classification for HIV-1 [J].
Berger, EA ;
Doms, RW ;
Fenyö, EM ;
Korber, BTM ;
Littman, DR ;
Moore, JP ;
Sattentau, QJ ;
Schuitemaker, H ;
Sodroski, J ;
Weiss, RA .
NATURE, 1998, 391 (6664) :240-240
[6]  
BERKHOUT B, EMERGING INFECT DIS, V4, P335
[7]  
Berkowitz RD, 1998, J IMMUNOL, V161, P3702
[8]   Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine [J].
Cafaro, A ;
Caputo, A ;
Fracasso, C ;
Maggiorella, MT ;
Goletti, D ;
Baroncelli, S ;
Pace, M ;
Sernicola, L ;
Koanga-Mogtomo, ML ;
Betti, M ;
Borsetti, A ;
Belli, R ;
Åkerblom, L ;
Corrias, F ;
Buttò, S ;
Heeney, J ;
Verani, P ;
Titti, F ;
Ensoli, B .
NATURE MEDICINE, 1999, 5 (06) :643-650
[9]   Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry [J].
Chen, ZW ;
Zhou, P ;
Ho, DD ;
Landau, NR ;
Marx, PA .
JOURNAL OF VIROLOGY, 1997, 71 (04) :2705-2714
[10]   Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes [J].
Chesebro, B ;
Wehrly, K ;
Nishio, J ;
Perryman, S .
JOURNAL OF VIROLOGY, 1996, 70 (12) :9055-9059